Impact of previous disease-modifying treatment on safety and efficacy in patients with MS treated with AHSCT | Journal of Neurology, Neurosurgery & Psychiatry

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

JNNP 100

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Multiple sclerosis

Original research

Impact of previous disease-modifying treatment on safety and efficacy in patients with MS treated with AHSCT

Online download statistics by month:

Online download statistics by month: May 2022 to March 2024

	Abstract	Full	Pdf
May 2022	887	893	210
Jun 2022	404	409	57
Jul 2022	595	601	99
Aug 2022	308	305	84
Sep 2022	140	141	69
Oct 2022	101	100	27
Nov 2022	80	81	92
Dec 2022	67	69	16
Jan 2023	58	58	35
Feb 2023	89	87	25
Mar 2023	54	48	29
Apr 2023	42	41	34
May 2023	51	46	28
Jun 2023	31	32	16
Jul 2023	42	42	25
Aug 2023	27	25	11
Sep 2023	33	31	16
Oct 2023	34	35	11
Nov 2023	34	32	17
Dec 2023	29	26	11
Jan 2024	24	24	14
Feb 2024	68	68	31
Mar 2024	51	49	29
Total	3249	3243	986